Related Experiment Videos
A computational tool to optimize ligand selectivity between two similar biomacromolecular targets
Deliang L Chen1, Glen E Kellogg
1Department of Medicinal Chemistry & Institute for Structural Biology and Drug Discovery, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298-0540, USA.
Journal of Computer-Aided Molecular Design
|August 3, 2005
Summary
This study introduces a new computer program that enhances ligand-receptor selectivity by modifying ligand structures in silico. The program uses computational methods to improve binding affinity to target proteins, aiding drug design and inhibitor development.
Area of Science:
- Computational chemistry
- Molecular modeling
- Drug discovery
Background:
- Achieving specific ligand-receptor interactions is crucial for targeted therapies and inhibitor design.
- Existing methods often lack the precision to fine-tune selectivity between closely related protein targets.
Purpose of the Study:
- To describe algorithms for a novel computer program aimed at increasing ligand-receptor selectivity.
- To demonstrate the program's capability in modifying ligand structures for enhanced binding affinity and selectivity.
Main Methods:
- In silico modification of ligand structures using steric and hydropathic complementarity rules.
- Calculation of relative binding scores using grid-based steric penalty, hydrogen bond complementarity, and the HINT score model.
- Application of the program to modify CB3717 for thymidylate synthase selectivity and design selective inhibitors for 4-hydroxyphenylpyruvate dioxygenase.
Main Results:
- The program successfully identified modifications to CB3717 to improve selectivity towards wild type L. casei thymidylate synthase or its E60Q mutant.
- New selective inhibitors for plant 4-hydroxyphenylpyruvate dioxygenase were designed, demonstrating the program's utility in creating targeted herbicides.
Conclusions:
- The developed computational program effectively enhances ligand-receptor selectivity through in silico ligand modification.
- This approach offers a powerful tool for designing targeted drugs and selective enzyme inhibitors.